Stay informed with the latest litigation news. Explore now

IP Verse

Alexion Pharmaceuticals competitive analysis

Latest publications and patents of Alexion Pharmaceuticals New

Explore the latest publications and patents granted to Alexion Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 12, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Alexion Pharmaceuticals

EP3167888
May 1, 2024Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementGranted And Under Opposition
EP2894165
Jan 4, 2023Methods And Compositions For Treating Complement-Associated DisordersGranted And Under Opposition
EP2978451
Nov 27, 2019Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C5Revoked
EP3207132
Jul 31, 2019Methods Of Shifting An Isoelectric Profile Of A Protein Product And Uses ThereofRevoked

Latest oppositions filed by Alexion Pharmaceuticals

Explore patent oppositions filed by Alexion Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2708559
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 31, 2018
EP2708558
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 21, 2018
EP2552955
Antibodies With Modified Affinity To Fcrn That Promote Antigen ClearanceCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 2, 2018

Latest patents of Alexion Pharmaceuticals opposed by its competitors

Explore Alexion Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3167888
May 1, 2024Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement3
EP2894165
Jan 4, 2023Methods And Compositions For Treating Complement-Associated Disorders2
EP2978451
Nov 27, 2019Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C52
EP3207132
Jul 31, 2019Methods Of Shifting An Isoelectric Profile Of A Protein Product And Uses Thereof1

Latest PTAB cases involving Alexion Pharmaceuticals New

Discover the latest PTAB cases involving Alexion Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 18, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Alexion Pharmaceuticals

IPR2023-01070Jun 16, 2023SAMSUNG BIOEPISALEXION PHARMACEUTICALSTerminated-Settled
IPR2023-01069Jun 16, 2023SAMSUNG BIOEPISALEXION PHARMACEUTICALSTerminated-Settled
IPR2023-00999May 31, 2023SAMSUNG BIOEPISALEXION PHARMACEUTICALSTerminated-Settled
IPR2023-00998May 31, 2023SAMSUNG BIOEPISALEXION PHARMACEUTICALSTerminated-Settled
IPR2023-00933May 18, 2023SAMSUNG BIOEPISALEXION PHARMACEUTICALSTerminated-Settled
IPR2019-00741Feb 28, 2019AMGENALEXION PHARMACEUTICALSTerminated-Settled
IPR2019-00740Feb 28, 2019AMGENALEXION PHARMACEUTICALSTerminated-Settled
IPR2019-00739Feb 28, 2019AMGENALEXION PHARMACEUTICALSTerminated-Settled

Top competitors of Alexion Pharmaceuticals

Top competitors of Alexion Pharmaceuticals based on patent oppositions.